Robert E. Ratner
- Endocrinology, Diabetes and Metabolism top 0.02%
- Diabetes Treatment and Management 69
- Diabetes Management and Research 57
- Diabetes, Cardiovascular Risks, and Lipoproteins 41
- Obstetrics and Gynecology top 0.2%
- Gestational Diabetes Research and Management 13
- Surgery top 0.2%
- Pancreatic function and diabetes 31
- Nephrology top 0.5%
- Pharmacy top 0.5%
-
- Metabolism, Diabetes, and Cancer 39
-
- Diet and metabolism studies 14
-
- Diabetes and associated disorders 14
- Co-authors
- Mark FinemanJenny HanDennis Dong Hwan KimRalph A. DeFronzoAlain BaronSarah FowlerRobert R. HenryBruce W. Bode
- Partner nations
- United StatesUnited KingdomCanada
In The Last Decade
Robert E. Ratner
157 papers receiving 15.8k citations
Hit Papers
Peers
Comparison fields: 5 of 166
- Endocrinology, Diabetes and Metabolism 10.7k
- Obstetrics and Gynecology 1.4k
- Surgery 5.1k
- Nephrology 807
- Pharmacy 493
Countries citing papers authored by Robert E. Ratner
This map shows the geographic impact of Robert E. Ratner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert E. Ratner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert E. Ratner more than expected).
Fields of papers citing papers by Robert E. Ratner
This network shows the impact of papers produced by Robert E. Ratner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert E. Ratner. The network helps show where Robert E. Ratner may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Robert E. Ratner, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2020 | 72 | |
| 3 | 2016 | 35 | |
| 4 | Effectiveness and cost-effectiveness of diabetes prevention among adherent participants. | 2013 | 71 |
| 5 | 2013 | 34 | |
| 6 | 2013 | 1 | |
| 7 | 2011 | 16 | |
| 8 | 2011 | 37 | |
| 9 | 2011 | 25 | |
| 10 | 2010 | 37 | |
| 11 | 2010 | 156 | |
| 12 | Stop Atherosclerosis in Native Diabetics Study (SANDS): Baseline Characteristics of the Randomized Cohort | 2009 | 4 |
| 13 | 2009 | 49 | |
| 14 | 2008 | 13 | |
| 15 | 2008 | 171 | |
| 16 | Effects of exenatide (exendin-4) on glycemic control and weight over 30 weeks in metformin-treated patients with Type 2 diabetes | 2004 | 2 |
| 17 | 2003 | 47 | |
| 18 | 2001 | 23 | |
| 19 | 1994 | 4 | |
| 20 | 1988 | 35 |
About Robert E. Ratner
Robert E. Ratner is a scholar working on Endocrinology, Diabetes and Metabolism, Obstetrics and Gynecology and Pharmacy, having authored 159 papers that have together received 16.6k indexed citations. Recurring topics across this work include Diabetes Treatment and Management (69 papers), Diabetes Management and Research (57 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (41 papers), Metabolism, Diabetes, and Cancer (39 papers), Pancreatic function and diabetes (31 papers), Diet and metabolism studies (14 papers), Diabetes and associated disorders (14 papers) and Gestational Diabetes Research and Management (13 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (10.7k citations), Obstetrics and Gynecology (1.4k citations) and Surgery (5.1k citations). Robert E. Ratner has collaborated with scholars based in United States, United Kingdom and Canada. Frequent co-authors include Mark Fineman, Jenny Han, Dennis Dong Hwan Kim, Ralph A. DeFronzo, Alain Baron, Sarah Fowler, Robert R. Henry, Bruce W. Bode, Irl B. Hirsch and Vanita R. Aroda. Their work appears in journals such as Diabetes Care, Diabetes Obesity and Metabolism, Diabetes, Diabetic Medicine and The Journal of Clinical Endocrinology & Metabolism.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.